Literature DB >> 8566837

5-Aminosalicylic acid inhibits the impaired epithelial barrier function induced by gamma interferon.

M C Di Paolo1, M N Merrett, B Crotty, D P Jewell.   

Abstract

Gamma interferon (IFN gamma) impairs epithelial barrier function and induces HLA-DR expression on colonic cancer cell lines. Salicylates have been shown to reduce IFN gamma induced HLA-DR expression. The effect of 5-aminosalicylic acid (5-ASA) on IFN gamma induced changes in transepithelial resistance and permeability was investigated in HT29 clone 19A and Caco 2 monolayers. Monolayers were incubated with different concentrations of IFN gamma (100, 500, 1000, and 3000 U/ml) and 5-ASA. IFN gamma induced class II expression in a time and dose dependent manner in HT29:19A but not Caco 2 cells. HT29:19A monolayers incubated with both IFN gamma and 5-ASA showed lower HLA-DR expression compared with monolayers incubated with IFN gamma alone. Electrical resistance and 14C-mannitol flux across HT29:19A monolayers were significantly changed by IFN gamma. Addition of both IFN gamma and 5-ASA to the basolateral surface of the monolayers significantly reduced paracellular permeability compared with addition of IFN gamma alone. These data show that IFN gamma is able to induce HLA-DR expression and to impair the barrier function of HT29:19A monolayers, and that 5-ASA reduces IFN gamma induced HLA-DR expression and inhibits the effects of IFN gamma on epithelial barrier function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8566837      PMCID: PMC1382988          DOI: 10.1136/gut.38.1.115

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  18 in total

1.  Biological effects of gamma-interferon on human tumor cells: quantity and affinity of cell membrane receptors for gamma-IFN in relation to growth inhibition and induction of HLA-DR expression.

Authors:  U Ucer; H Bartsch; P Scheurich; K Pfizenmaier
Journal:  Int J Cancer       Date:  1985-07-15       Impact factor: 7.396

2.  HLA-DR antigens on colonic epithelial cells in inflammatory bowel disease: I. Relation to the state of activation of lamina propria lymphocytes and to the epithelial expression of other surface markers.

Authors:  S Fais; F Pallone; O Squarcia; L Biancone; F Ricci; P Paoluzi; M Boirivant
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

3.  Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease.

Authors:  W S Selby; G Janossy; D Y Mason; D P Jewell
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

4.  Small bowel and colonic permeability to 51Cr-EDTA in patients with active inflammatory bowel disease.

Authors:  R T Jenkins; J K Ramage; D B Jones; S M Collins; R L Goodacre; R H Hunt
Journal:  Clin Invest Med       Date:  1988-04       Impact factor: 0.825

5.  Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate.

Authors:  C Augeron; C L Laboisse
Journal:  Cancer Res       Date:  1984-09       Impact factor: 12.701

6.  Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers.

Authors:  J L Madara; J Stafford
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

7.  Expression of HLA-DR antigens on epithelium associated with lymphoid tissue in the human gastrointestinal tract.

Authors:  J Spencer; T Finn; P G Isaacson
Journal:  Gut       Date:  1986-02       Impact factor: 23.059

8.  Interferon-gamma induces a cell surface phenotype switch on T84 intestinal epithelial cells.

Authors:  S P Colgan; C A Parkos; J B Matthews; L D'Andrea; C S Awtrey; A H Lichtman; C Delp-Archer; J L Madara
Journal:  Am J Physiol       Date:  1994-08

9.  Induction of various HLA class II molecules in a human colonic adenocarcinoma cell line.

Authors:  L M Sollid; G Gaudernack; G Markussen; D Kvale; P Brandtzaeg; E Thorsby
Journal:  Scand J Immunol       Date:  1987-02       Impact factor: 3.487

10.  Evidence for function of Ia molecules on gut epithelial cells in man.

Authors:  L Mayer; R Shlien
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

View more
  16 in total

Review 1.  Cytokine regulation of epithelial permeability and ion transport.

Authors:  D M McKay; A W Baird
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

Review 2.  Prolonged-release mesalazine: a review of its therapeutic potential in ulcerative colitis and Crohn's disease.

Authors:  D Clemett; A Markham
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

3.  Augmented increase in tight junction permeability by luminal stimuli in the non-inflamed ileum of Crohn's disease.

Authors:  J D Söderholm; G Olaison; K H Peterson; L E Franzén; T Lindmark; M Wirén; C Tagesson; R Sjödahl
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

4.  Balsalazine decreases intestinal mucosal permeability of dextran sulfate sodium-induced colitis in mice.

Authors:  Xiao-Chang Liu; Qiao Mei; Jian-Ming Xu; Jing Hu
Journal:  Acta Pharmacol Sin       Date:  2009-07       Impact factor: 6.150

5.  Protein transport and processing by human HT29-19A intestinal cells: effect of interferon gamma.

Authors:  K Terpend; F Boisgerault; M A Blaton; J F Desjeux; M Heyman
Journal:  Gut       Date:  1998-04       Impact factor: 23.059

6.  Commensal bacterial internalization by epithelial cells: An alternative portal for gut leakiness.

Authors:  Linda Chia-Hui Yu
Journal:  Tissue Barriers       Date:  2015-02-23

7.  Increased epithelial uptake of protein antigens in the ileum of Crohn's disease mediated by tumour necrosis factor alpha.

Authors:  J D Söderholm; C Streutker; P-C Yang; C Paterson; P K Singh; D M McKay; P M Sherman; K Croitoru; M H Perdue
Journal:  Gut       Date:  2004-12       Impact factor: 23.059

8.  Update on the role of modified release mesalamine in the management of ulcerative colitis and Crohn's disease.

Authors:  Glen A Doherty; Mark A Peppercorn
Journal:  Clin Exp Gastroenterol       Date:  2009-12-08

Review 9.  Mechanism of cytokine modulation of epithelial tight junction barrier.

Authors:  Rana Al-Sadi; Michel Boivin; Thomas Ma
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

10.  Inhibition of Sphingosine-1-Phosphate-Induced Th17 Cells Ameliorates Alcohol-Associated Steatohepatitis in Mice.

Authors:  Shenghui Chu; Rui Sun; Xuemei Gu; Liang Chen; Min Liu; HaiXun Guo; Songwen Ju; Vatsalya Vatsalya; Wenke Feng; Craig J McClain; Zhongbin Deng
Journal:  Hepatology       Date:  2021-03       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.